Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Acq. announced

Khosla Ventures Acquisition Co. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/24/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
06/12/2023 8-K Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submiss...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Amendment to the Second Amended and Restated Certificate of Incorporation of the Company",
"Amendment No. 1 to the Investment Management Trust Agreement, entered into between the Company and Continental Stock Transfer & Trust Company"
06/02/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/19/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
05/15/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/12/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
05/05/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
03/31/2023 10-K Annual Report for the period ended December 31, 2022
03/10/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
02/14/2023 8-K Regulation FD Disclosure  Interactive Data
02/14/2023 SC 13G/A Sculptor Capital LP reports a 5.8% stake in KHOSLA VENTURES ACQUISITION CO.
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
08/11/2022 10-Q Quarterly Report for the period ended June 30, 2022
05/13/2022 10-Q Quarterly Report for the period ended March 31, 2022
03/31/2022 10-K Annual Report for the period ended December 31, 2021
03/31/2022 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
03/14/2022 8-K Quarterly results
02/14/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
02/14/2022 SC 13G/A CITADEL ADVISORS LLC reports a 6.6% stake in Khosla Ventures Acquisition Co.
02/11/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/09/2022 SC 13G/A BlackRock Inc. reports a 4.7% stake in Khosla Ventures Acquisition Co
02/02/2022 SC 13G Sculptor Capital LP reports a 5.8% stake in KHOSLA VENTURES ACQUISITION CO.
01/31/2022 SC 13G/A INTEGRATED CORE STRATEGIES LLC reports a 3.5% stake in KHOSLA VENTURES ACQUISITION CO. III
01/18/2022 SC 13G/A INTEGRATED CORE STRATEGIES LLC reports a 3.8% stake in KHOSLA VENTURES ACQUISITION CO.
11/29/2021 SC 13G CITADEL ADVISORS LLC reports a 6.3% stake in Khosla Ventures Acquisition Co.
11/15/2021 8-K Termination of a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive ...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Valo Health and Khosla Ventures Acquisition Co. Mutually Agree to Terminate Business Combination Agreement"
11/09/2021 425 Form 425 - Prospectuses and communications, business combinations:
11/09/2021 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Stat...
Docs: "Valo Health and Khosla Ventures Acquisition Co. Announce Additional PIPE Commitments • Additional PIPE commitments since SPAC announcement total $33.5M • Anticipated PIPE proceeds total over $200M exceeding initial targets • New commitments made by CEO & Founder, David Berry and CFO, Graeme Bell BOSTON, MA and MENLO PARK, CA, November 9, 2021 — Valo Health, LLC , the technology company using human-centric data and artificial intelligence powered computation to transform the drug discovery and development process, and Khosla Ventures Acquisition Co. , a special purpose acquisition company sponsored by an affiliate of Khosla Ventures, LLC , today announced that the private placement of common stock investment in connection with their previously announced business combination had expanded fro..."
11/08/2021 425 Form 425 - Prospectuses and communications, business combinations:
11/05/2021 10-Q Quarterly Report for the period ended September 30, 2021
10/28/2021 425 Form 425 - Prospectuses and communications, business combinations:
10/28/2021 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure...
Docs: "Valo"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy